ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,318.735
0.46%
Brent Oil
83.685
0.15%
Bitcoin
61,626.59
0.72%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)

  7. ProQR Therapeutics NV (PRQR) News

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRQR
DateTimeSourceHeadlineSymbolCompany
08/05/202413:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
15/02/202412:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
14/02/202411:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
09/02/202411:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
19/01/202412:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
05/01/202412:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
07/11/202315:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
27/09/202312:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
14/09/202322:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
03/08/202312:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
01/08/202312:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
16/05/202312:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
25/04/202311:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
24/04/202321:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
29/03/202321:55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
29/03/202321:54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
29/03/202321:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
10/03/202321:10Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
14/02/202315:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
09/02/202322:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
09/02/202317:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
09/02/202316:59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
08/02/202311:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
23/12/202221:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
23/12/202212:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
10/11/202211:35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
09/11/202220:40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
09/11/202212:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
21/09/202221:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
12/08/202202:15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
 Showing the most relevant articles for your search:NASDAQ:PRQR

Your Recent History

LSE
ALBA
Alba Mineral Resources
LSE
BOO
Boohoo
LSE
GGP
Greatland Gold
LSE
ENET
Ethernity Networks
LSE
SCE
Surface Transforms
LSE
EDEN
Eden Research
LSE
GKP
Gulf Keystone Petroleum
LSE
VAST
Vast Resources
LSE
BARC
Barclays
LSE
MNL
Manchester & London Inve...
LSE
RKH
Rockhopper Exploration
LSE
ALGW
Alpha Growth
LSE
NSCI
Netscientific
LSE
ASC
Asos
LSE
SBRY
Sainsbury (j)
LSE
JIM
Jarvis Securities
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved